J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
1,622.20
+7.45 (0.46%)
At close: Mar 28, 2025
BOM:506943 Revenue
J. B. Chemicals & Pharmaceuticals had revenue of 9.63B INR in the quarter ending December 31, 2024, with 14.09% growth. This brings the company's revenue in the last twelve months to 38.30B, up 13.16% year-over-year. In the fiscal year ending March 31, 2024, J. B. Chemicals & Pharmaceuticals had annual revenue of 34.84B with 10.63% growth.
Revenue (ttm)
38.30B
Revenue Growth
+13.16%
P/S Ratio
6.28
Revenue / Employee
7.21M
Employees
5,311
Market Cap
241.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
Mar 31, 2021 | 20.43B | 2.68B | 15.09% |
Mar 31, 2020 | 17.75B | 1.32B | 8.00% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
HDFC Bank | 2,702.59B |
Tata Consultancy Services | 2,520.82B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 1,755.26B |
State Bank of India | 3,409.52B |
Infosys | 1,635.60B |
Bajaj Finance | 358.05B |
J. B. Chemicals & Pharmaceuticals News
- 5 days ago - JB Chemicals & Pharma shares slide 6% after large block deal of 5.7% equity - Business Upturn
- 6 days ago - Stocks to watch today: Infosys, Wipro, Ashok Leyland, HUL, Bajaj Finance, BSE, NBCC, UPL, Max Financial, JB Chemicals in focus [27 March] - Business Upturn
- 6 days ago - Stocks to watch today: JB Chemicals, Infosys, Bajaj Finserv, Wipro, Bharat Forge, Marico, Sterlite Technologies in focus on March 26, 2025 - Business Upturn
- 6 days ago - KKR, JB Chemicals promoter, to sell 10% for Rs 2.6k crore - The Times of India
- 6 days ago - JB Chemicals and Pharma: Promoter KKR entity to sell 10.2% stake worth Rs 2,575 crore via block tomorrow - Business Upturn
- 5 months ago - KKR Is Said to Consider Selling $750 Million Stake in JB Pharma - BNN Bloomberg
- 5 months ago - Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside - Business Upturn
- 6 months ago - Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83% - Business Upturn